Accumulating evidences suggested that H19 was up-regulated in a variety of cancer types, including breast cancer [19, 20], esophageal cancer [21], bladder cancer [22] and colorectal cancer [23]. This evidence concerns the gene H19 and urinary bladder carcinoma.